I seek leave to amend general business notice of motion No. 3 in the terms circulated in the chamber.

Leave granted.

I move the motion as amended:

That the following matters be referred to the Community Affairs References Committee for inquiry and report by 22 April 2013:

(a) the supply of chemotherapy drugs such as Docetaxel, particularly in relation to:

(i) patient access to treatment,

(ii) cost to pharmacists and suppliers, and

(iii) cost to the private and public hospital systems;

(b) any long-term sustainable funding models for the supply of chemotherapy drugs, including Docetaxel; and

(c) any related matters.

Question agreed to.